New York State Common Retirement Fund Decreases Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

New York State Common Retirement Fund lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 8.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 512,292 shares of the company's stock after selling 48,537 shares during the period. New York State Common Retirement Fund owned approximately 0.11% of GE HealthCare Technologies worth $39,610,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in GEHC. AE Wealth Management LLC raised its position in GE HealthCare Technologies by 4.0% in the third quarter. AE Wealth Management LLC now owns 10,810 shares of the company's stock worth $735,000 after purchasing an additional 420 shares in the last quarter. IFP Advisors Inc grew its stake in GE HealthCare Technologies by 53.8% during the third quarter. IFP Advisors Inc now owns 2,320 shares of the company's stock worth $158,000 after buying an additional 812 shares during the last quarter. HB Wealth Management LLC grew its stake in GE HealthCare Technologies by 34.5% during the third quarter. HB Wealth Management LLC now owns 4,504 shares of the company's stock worth $306,000 after buying an additional 1,155 shares during the last quarter. Avior Wealth Management LLC grew its stake in GE HealthCare Technologies by 35.5% during the third quarter. Avior Wealth Management LLC now owns 1,369 shares of the company's stock worth $93,000 after buying an additional 359 shares during the last quarter. Finally, Private Trust Co. NA grew its stake in GE HealthCare Technologies by 53.9% during the third quarter. Private Trust Co. NA now owns 1,808 shares of the company's stock worth $123,000 after buying an additional 633 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently commented on GEHC shares. UBS Group raised shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and increased their price target for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Argus increased their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a "buy" rating in a research note on Monday, April 1st. Evercore ISI increased their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an "outperform" rating in a research note on Thursday, April 4th. HSBC initiated coverage on shares of GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a "buy" rating and a $100.00 price objective on the stock. Finally, Morgan Stanley raised their price objective on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an "equal weight" rating in a research note on Monday, February 12th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $95.09.

GE HealthCare Technologies Stock Down 0.9 %

Shares of GE HealthCare Technologies stock traded down $0.77 during trading on Thursday, reaching $85.95. The stock had a trading volume of 1,362,869 shares, compared to its average volume of 3,316,483. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $39.22 billion, a price-to-earnings ratio of 28.72, a P/E/G ratio of 3.00 and a beta of 0.94. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The stock has a fifty day moving average price of $88.91 and a two-hundred day moving average price of $78.27.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.07 by $0.11. The firm had revenue of $5.20 billion for the quarter, compared to analysts' expectations of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business's quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.31 EPS. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies's payout ratio is currently 3.97%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.